{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-3001"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-3001","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Ingesting and inhaling: understanding the synergistic effects of high-fat diet and nicotine e-vape on the brain and metabolic health","abstract":"Smoking is a major public health concern. Despite decades of accumulated evidence of the negative health consequences, smoking remains the leading cause of preventable death in the United States, with about 500,000 deaths each year. Whereas the use of combustible cigarettes has declined in the United States, the use of electronic nicotine delivery systems (ENDS) has increased drastically. Nicotine, the psychoactive ingredient in tobacco and ENDS products, has been shown to induce its reinforcing properties by directly activating dopaminergic, GABAergic, and glutamatergic neurons within the ventral tegmental area. It is well-documented that the activation of the ventral tegmental area by nicotine stimulates the release of dopamine, which projects to the nucleus accumbens and the prefrontal cortex. In addition to its neurophysiological complications, the usage of nicotine-containing products is associated with chronic diseases such as respiratory and cardiovascular diseases, cancers, and diabetes. The surge in the mortality rate and comorbidities associated with smoking has prompted efforts to identify factors that enhance nicotine abuse liability. One of the factors currently under investigation is obesity-inducing diets (e.g. high-fat and high-sugar diets). Preliminary findings suggest that excessive consumption of obesity-inducing diets could cause neuroadaptive changes in the reward pathway, potentially influencing drug use. Despite this knowledge, few studies have examined the exact neurochemical mechanisms mediating high-fat diet-induced obesity and nicotine addiction in preclinical models. To address this limitation, Chapters 1 and 2 of this dissertation review the neurobiological properties of nicotine and obesity through the lens of the dopamine reward pathway. In Chapter 3, we examine the influence of high-fat diet on nicotine reinforcement- and motivation-related behavior in a model system that mimics human vaping. In Chapter 4, we explore the synergistic effects of obesogenic diet and vaporized nicotine exposure on ventral tegmental area dopamine physiology, cell integrity, and metabolic health in adult mice. Additionally, this dissertation investigates whether nicotine doses and/or popular flavoring additives found in nicotine-containing products mediate vaping-related behaviors in diet-induced obese adult mice. With the rise in fast-food culture and the continued high numbers of smoking-related deaths, these findings offer an insight into the exact mechanisms modulating comorbid conditions such as obesity and smoking (including vaping).","abstract_html":"Smoking is a major public health concern. Despite decades of accumulated evidence of the negative health consequences, smoking remains the leading cause of preventable death in the United States, with about 500,000 deaths each year. Whereas the use of combustible cigarettes has declined in the United States, the use of electronic nicotine delivery systems (ENDS) has increased drastically. Nicotine, the psychoactive ingredient in tobacco and ENDS products, has been shown to induce its reinforcing properties by directly activating dopaminergic, GABAergic, and glutamatergic neurons within the ventral tegmental area. It is well-documented that the activation of the ventral tegmental area by nicotine stimulates the release of dopamine, which projects to the nucleus accumbens and the prefrontal cortex. In addition to its neurophysiological complications, the usage of nicotine-containing products is associated with chronic diseases such as respiratory and cardiovascular diseases, cancers, and diabetes. The surge in the mortality rate and comorbidities associated with smoking has prompted efforts to identify factors that enhance nicotine abuse liability. One of the factors currently under investigation is obesity-inducing diets (e.g. high-fat and high-sugar diets). Preliminary findings suggest that excessive consumption of obesity-inducing diets could cause neuroadaptive changes in the reward pathway, potentially influencing drug use. Despite this knowledge, few studies have examined the exact neurochemical mechanisms mediating high-fat diet-induced obesity and nicotine addiction in preclinical models. To address this limitation, Chapters 1 and 2 of this dissertation review the neurobiological properties of nicotine and obesity through the lens of the dopamine reward pathway. In Chapter 3, we examine the influence of high-fat diet on nicotine reinforcement- and motivation-related behavior in a model system that mimics human vaping. In Chapter 4, we explore the synergistic effects of obesogenic diet and vaporized nicotine exposure on ventral tegmental area dopamine physiology, cell integrity, and metabolic health in adult mice. Additionally, this dissertation investigates whether nicotine doses and/or popular flavoring additives found in nicotine-containing products mediate vaping-related behaviors in diet-induced obese adult mice. With the rise in fast-food culture and the continued high numbers of smoking-related deaths, these findings offer an insight into the exact mechanisms modulating comorbid conditions such as obesity and smoking (including vaping).","abstract_has_math":false,"creators":["Tetteh-Quarshie, Samuel"],"institution":null,"degree_name":"Biomedical Research","degree_level":"Dissertation","degree_discipline":"Joan C. Edwards School of Medicine","degree_department":null,"school":null,"contributors":["Dr. Brandon Henderson","Dr. Mary-Louise Risher","Dr. Cynthia Jones"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:17Z","subjects":["Medical Pharmacology","Medical Sciences","Medicine and Health Sciences","Neurosciences","Public Health","Social and Behavioral Sciences","dopamine","glucose","high-fat diet","nicotine","obesity","self-administration"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1996","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1996","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-3001","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Brandon Henderson","Dr. Mary-Louise Risher","Dr. Cynthia Jones"]},{"key":"dc:creator","label":"Author","values":["Tetteh-Quarshie, Samuel"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-11-17T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2025-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Joan C. Edwards School of Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Biomedical Research"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Pharmacology","Medical Sciences","Medicine and Health Sciences","Neurosciences","Public Health","Social and Behavioral Sciences","dopamine","glucose","high-fat diet","nicotine","obesity","self-administration"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1996"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Smoking is a major public health concern. Despite decades of accumulated evidence of the negative health consequences, smoking remains the leading cause of preventable death in the United States, with about 500,000 deaths each year. Whereas the use of combustible cigarettes has declined in the United States, the use of electronic nicotine delivery systems (ENDS) has increased drastically. Nicotine, the psychoactive ingredient in tobacco and ENDS products, has been shown to induce its reinforcing properties by directly activating dopaminergic, GABAergic, and glutamatergic neurons within the ventral tegmental area. It is well-documented that the activation of the ventral tegmental area by nicotine stimulates the release of dopamine, which projects to the nucleus accumbens and the prefrontal cortex. In addition to its neurophysiological complications, the usage of nicotine-containing products is associated with chronic diseases such as respiratory and cardiovascular diseases, cancers, and diabetes. The surge in the mortality rate and comorbidities associated with smoking has prompted efforts to identify factors that enhance nicotine abuse liability. One of the factors currently under investigation is obesity-inducing diets (e.g. high-fat and high-sugar diets). Preliminary findings suggest that excessive consumption of obesity-inducing diets could cause neuroadaptive changes in the reward pathway, potentially influencing drug use. Despite this knowledge, few studies have examined the exact neurochemical mechanisms mediating high-fat diet-induced obesity and nicotine addiction in preclinical models. To address this limitation, Chapters 1 and 2 of this dissertation review the neurobiological properties of nicotine and obesity through the lens of the dopamine reward pathway. In Chapter 3, we examine the influence of high-fat diet on nicotine reinforcement- and motivation-related behavior in a model system that mimics human vaping. In Chapter 4, we explore the synergistic effects of obesogenic diet and vaporized nicotine exposure on ventral tegmental area dopamine physiology, cell integrity, and metabolic health in adult mice. Additionally, this dissertation investigates whether nicotine doses and/or popular flavoring additives found in nicotine-containing products mediate vaping-related behaviors in diet-induced obese adult mice. With the rise in fast-food culture and the continued high numbers of smoking-related deaths, these findings offer an insight into the exact mechanisms modulating comorbid conditions such as obesity and smoking (including vaping)."]},{"key":"dc:title","label":"Title","values":["Ingesting and inhaling: understanding the synergistic effects of high-fat diet and nicotine e-vape on the brain and metabolic health"]}]}],"canonical_facts":{"dc:contributor":["Dr. Brandon Henderson","Dr. Mary-Louise Risher","Dr. Cynthia Jones"],"dc:creator":["Tetteh-Quarshie, Samuel"],"dc:date.available":["2026-11-17T08:00:00Z"],"dc:date.created":["2025-01-01T08:00:00Z"],"dc:description.abstract":["Smoking is a major public health concern. Despite decades of accumulated evidence of the negative health consequences, smoking remains the leading cause of preventable death in the United States, with about 500,000 deaths each year. Whereas the use of combustible cigarettes has declined in the United States, the use of electronic nicotine delivery systems (ENDS) has increased drastically. Nicotine, the psychoactive ingredient in tobacco and ENDS products, has been shown to induce its reinforcing properties by directly activating dopaminergic, GABAergic, and glutamatergic neurons within the ventral tegmental area. It is well-documented that the activation of the ventral tegmental area by nicotine stimulates the release of dopamine, which projects to the nucleus accumbens and the prefrontal cortex. In addition to its neurophysiological complications, the usage of nicotine-containing products is associated with chronic diseases such as respiratory and cardiovascular diseases, cancers, and diabetes. The surge in the mortality rate and comorbidities associated with smoking has prompted efforts to identify factors that enhance nicotine abuse liability. One of the factors currently under investigation is obesity-inducing diets (e.g. high-fat and high-sugar diets). Preliminary findings suggest that excessive consumption of obesity-inducing diets could cause neuroadaptive changes in the reward pathway, potentially influencing drug use. Despite this knowledge, few studies have examined the exact neurochemical mechanisms mediating high-fat diet-induced obesity and nicotine addiction in preclinical models. To address this limitation, Chapters 1 and 2 of this dissertation review the neurobiological properties of nicotine and obesity through the lens of the dopamine reward pathway. In Chapter 3, we examine the influence of high-fat diet on nicotine reinforcement- and motivation-related behavior in a model system that mimics human vaping. In Chapter 4, we explore the synergistic effects of obesogenic diet and vaporized nicotine exposure on ventral tegmental area dopamine physiology, cell integrity, and metabolic health in adult mice. Additionally, this dissertation investigates whether nicotine doses and/or popular flavoring additives found in nicotine-containing products mediate vaping-related behaviors in diet-induced obese adult mice. With the rise in fast-food culture and the continued high numbers of smoking-related deaths, these findings offer an insight into the exact mechanisms modulating comorbid conditions such as obesity and smoking (including vaping)."],"dc:identifier":["https://mds.marshall.edu/etd/1996"],"dc:subject":["Medical Pharmacology","Medical Sciences","Medicine and Health Sciences","Neurosciences","Public Health","Social and Behavioral Sciences","dopamine","glucose","high-fat diet","nicotine","obesity","self-administration"],"dc:title":["Ingesting and inhaling: understanding the synergistic effects of high-fat diet and nicotine e-vape on the brain and metabolic health"],"thesis:degree_discipline":["Joan C. Edwards School of Medicine"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Biomedical Research"]},"updated_at":"2026-11-21T19:58:17Z"}